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The invasion process of S. flexneri is well characterized, but mechanisms underlying this bacterium’s
adhesion to host cells have remained obscure. In this issue of Cell Host & Microbe, Brotcke Zumsteg et al.
(2014) report a surprising role for the Shigella virulence factor IcsA (VirG) as an adhesin.Shigella flexneri is a model pathogen. It
has been used extensively to study type
III secretion, a cytosolic pathogenic life-
style, cytosolic immune surveillance, and
actin polymerization. In each of these
aspects, S. flexneri has contributed to sig-
nificant advances in cellular microbiology.
However, in order for all of these intracel-
lular steps to occur, the bacterium must
first make contact with host cells. Mecha-
nistic insight into S. flexneri adherence to
host cells has eluded researchers for
decades. Shigella was missing an impor-
tant virulence factor: an adhesin.
In a landmark discovery in the 1980s,
the protein IcsA (VirG) was shown to
mediate intercellular spread (Makino
et al., 1986; Bernardini et al., 1989). IcsA
localizes to the outer membrane in an
asymmetric manner, accumulating at
one bacterial pole. By recruiting host cell
actin via N-WASP, IcsA is able to create
a comet tail that thrusts the bacterium
into neighboring host cells (Figure 1).
Slightly later, the discovery of the Mxi-
Spa type III secretion system (T3SS) facil-
itated our understanding of the invasion
process and highlighted the role of IpaB
and IpaDproteins asmajor invasins. How-
ever, until recently, it was not known that
IcsA and the T3SS influence each other.
To identify adhesins in S. flexneri,
Brotcke Zumsteg et al. (2014) started
with an old but astute observation that
Shigella strain lacking IpaB or IpaD is
hyperadhesive (Me´nard et al., 1994).
Here, the authors confirmed the hyperad-
hesive phenotype of the two mutants in
a variety of cells lines. Surprisingly, scan-
ning electron microscopy (SEM) analysis
showed that the hyperadhesive mutants
predominantly contacted macrophages
and neutrophils using one pole, whereas
the wild-type strain tended to con-
tact cells using its long axis. This clueled to the remarkable hypothesis that
hyperadhesion to host cells is mediated
by one or more molecules with a polar
localization.
Because IcsA localizes to one pole, the
authors tested whether it contributed to
hyperadhesion. First, they showed that
deleting icsA abrogated hyperadhesion
of the DipaD mutant and at the same
time abolished polar adhesion to host
cells. To further investigate their finding,
the authors produced IcsA in a Shigella
strain cured of the virulence plasmid
(BS176). As both IcsA and the T3SS are
encoded on the large virulence plasmid,
this experiment allowed the authors to
uncouple these two virulence factors.
IcsA alone was not sufficient to induce
adhesion in BS176, and they concluded
from this experiment that an activation
step is required for IcsA-dependent adhe-
sion in Shigella. What is the activation
step? Strains lacking the ipaD gene are
constitutively active for T3SS expression,
leading the authors to logically conclude
that the adhesion capacity of IcsA is
somehow triggered upon T3SS activation
(Figure 1). In line with this hypothesis,
treatment with the bile salt deoxycholate
(DOC), a stimulus encountered by the
bacterium in the host intestine, induced
IcsA-dependent adhesion. Importantly,
DOC induced adhesion only when the
bacterium had an intact T3SS.
Next, they asked whether IcsA is suffi-
cient to promote adhesion to host cells in
the absence of the T3SS. To test this,
IcsA was expressed in E. coli. Paradoxi-
cally, and in contrast to plasmid-cured
Shigella, when IcsA was expressed in
E. coli, the bacterium adhered using
IcsA in the absence of an activation
step. While this reductionist experiment
demonstrates sufficiency of IcsA for
adhesion, the dissonant results betweenCell Host & MicrobE. coli and BS176 led the authors
to question whether IcsA might exist
in different conformations, only one of
which was adhesive. Indeed, the authors
found that when IcsA functioned as an
adhesin, it had an altered protease cleav-
age pattern compared to IcsA in non-
adhering strains. These intriguing results
will hopefully spur an in-depth bio-
chemical analysis of IcsA to substantiate
the findings.
These data suggested that IcsA plays a
dual role during shigellosis by promoting
both adhesion to host cells and intercel-
lular dissemination. To uncouple these
two functions, the authors screened an
IcsA mutant library for clones that were
unable to adhere but could still form
plaques. The successful identification
of this mutant then allowed the authors
to test in vivo whether IcsA-dependent
adhesion contributed to pathogenesis.
Indeed, an adhesion-deficient IcsA
mutant was attenuated in a mouse model
of shigellosis, cementing the role of IcsA
as an adhesin in Shigella.
While the work described answers the
long-standing question of what the adhe-
sin in Shigella is, it raisesmanymore inter-
esting questions that call for more explo-
ration. What sort of signaling cascade
connects the T3SS and IcsA? The authors
rule out MxiE and IpgC, two previously
described transcriptional regulators that
are active only upon T3S activation. This
suggests that an as-yet-undescribed
pathway might also be at play. Does IcsA
really exist in alternate conformations?
Or perhaps binding to another factor or
posttranslational modifications leads to
altered protease accessibility. These pos-
sibilities will require further investigation.
Another emerging question asks what
the host cell receptor for IcsA is. Interest-
ingly, IcsA-dependent adhesion does note 15, April 9, 2014 ª2014 Elsevier Inc. 393
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Figure 1. Model Summarizing the Crosstalk between the T3SS and the Dual Role of IcsA in Cell Adhesion and Bacterial Spread
Treatment with the bile salt deoxycholate (DOC), a stimulus encountered by the bacterium in the intestine, induces polar activation of the T3SS to produce an
adhesive form of IcsA (1). IcsA acts as an adhesin by binding to an as-yet-unidentified receptor (2). After bacterial entry, an active T3SS is required for vacuole lysis
(3 and 4). Once free within the cytoplasm, Shigella uses IcsA to bind to N-WASP to recruit and induce actin polymerization at one bacterial pole (5) (Egile et al.,
1999). The unilateral movement allows bacterial passage to neighboring adjacent cells (6), a step during which the T3SS is switched off. Next, bacteria lyse the
two cell membranes acquired during protrusion (7 and 8), a step requiring an activated T3SS. Lastly, free bacteria will restart a new infection process (9).
(I) Shigella escapes killing by autophagy upon IcsB binding to ATG5 (Ogawa et al., 2005). (II) In the icsB mutant background, IcsA binds to ATG5 to facilitate
bacterial killing by autophagy (Ogawa et al., 2005).
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restricted to humans, since IcsA contrib-
uted to adhesion of mouse and human
cells. Likewise, IcsA-dependent adhesion
did not show specificity for any cell type.
All previously identified IcsA interaction
partners in the host have a cytosolic local-
ization (Figure 1) (Suzuki et al., 1998, Egile
et al., 1999, Ogawa et al., 2005), suggest-
ing that finding the IcsA receptor will
require an unbiased fishing approach
with extracellular-exposed molecules.
The study also has important implica-
tions for vaccine design, an area that has
challenged Shigella researchers because
of the sheer diversity of serotypes. Several
vaccine candidates have relied on icsA
mutations to attenuate the bacterium for
live, oral delivery. Taking these new data
into consideration, this approach now ap-
pears to have two shortcomings. First, the
icsA mutant is not likely to adhere to the
intestines (Rahman et al., 2011), a prereq-
uisite for inducing immunity. Second, the
vaccine would never elicit antibodies
against IcsA if IcsA is missing. Since IcsA
is a conserved virulence factor and an
adhesin, it serves as an excellent target
for inducing broadly neutralizing Shigella394 Cell Host & Microbe 15, April 9, 2014 ª2antibodies. In this context, several works
reported that IpaD subunits induce anti-
bodies that are able to neutralize invasion
by Shigella of several serotypes. Perhaps
combining these strategies would provide
the immunogenicity necessary to prevent
shigellosis.
Another interesting concept raised
by the paper is the idea of crosstalk
between the T3SS and IcsA. Other
studies have hinted at this; one showed
that the T3S effector IpaC accumulates
at the same pole as IcsA prior to secre-
tion (Jaumouille´ et al., 2008). If there
is indeed coordination between these
disparate virulence strategies, it could
mean that the bacterium is primed to
deliver T3S effectors to the pole adhering
to host cells. Likewise, Campbell-Valois
et al. (2014) presented an additional link
between the T3SS and IcsA in a recent
issue of Cell Host & Microbe. The
authors developed a fluorescent reporter
to monitor activity of the T3SS during
invasion and intercellular spread. The
T3SS showed two spikes in activity,
during initial invasion of the bacterium
and during intercellular spread, when
the double membrane was degraded014 Elsevier Inc.(Figure 1). If Shigella was unable to
create actin comet tails, either because
of an icsA deletion or by interfering with
actin polymerization, the bacterium
could not reactivate the T3SS. This sug-
gests that the crosstalk goes in both di-
rections, where the T3SS is required for
activating adhesion through IcsA, but
that IcsA is also required for activation
of the T3SS in some instances. Future
experiments in the Shigella field will
require attentiveness to this emerging
dialog.
Last but not least, the retrieved lesson
from this study is to highly consider the
physiological environmental conditions
when studying the virulence process.
The paper of Brotcke Zumsteg et al.
(2014) will certainly open new research
avenues, including the revisiting of some
old accepted concepts.
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Establishing lifelong infection and periodically shedding infectious progeny is a successful strategy em-
ployed by several persistent pathogens. In this issue of Cell Host & Microbe, Pan et al. (2014) demonstrate
that a cell-type-specific host microRNA can restrict gene expression and pathogenicity of herpes simplex
virus 1, thereby promoting long-term infection.In any prolonged war, de´tente, a long-
term relaxation of strained relations or
tensions between two nations, represents
a desirable outcome. This also applies
for the ongoing war between host and
pathogen, and particularly so for those
pathogens that have long coevolved with
their hosts. For a virus, establishing life-
long infection maximizes the opportunity
to spread to more hosts, thereby pro-
viding an evolutionary advantage. Viruses
have evolved a number of strategies
for persistent infection, and arguably the
most elegant is latency. Latent viruses
can undergo a lytic growth phase, involv-
ing replication of the viral genome, pro-
duction of progeny virus, lysis of cells,
infection of neighboring cells, and spread
to other organisms. During this phase,
the virus also infects cells within the
host where it is able to establish latency.
Latency results in drastically reduced
expression of most viral genes and elimi-
nates the production of infectious pro-
geny, allowing the virus to evade the
immune response. Periodically, the virus
reactivates from this quiescent state in
response to a variety of environmental
cues and re-enters the lytic phase of its
life cycle.
Members of the Herpesviridae family
could be considered the champions oflatent infection. There are several human
pathogens in this family, including
Epstein-Barr virus, human cytomegalo-
virus (HCMV), varicella-zoster virus, and
herpes simplex virus type 1 (HSV-1).
HSV-1 replicates primarily in epithelial
cells but establishes latency in neural
ganglia. During latency HSV-1 limits
gene expression to a single locus, the
non-protein-coding latency-associated
transcript (LAT), and coordinately reduces
lytic gene expression to near-undetect-
able levels. Both viral and host factors
are believed to be involved in establish-
ing and maintaining latency in neuronal
cells, but the mechanisms are still poorly
understood.
In one sense, the latent phase of the
viral life cycle is simply the repression
of the lytic phase. In herpesviruses, the
immediate early (IE) genes drive initiation
of the lytic phase. In HSV-1, the IE viral
protein ICP0 is required for reactivation
(Boutell and Everett, 2013) and for con-
trolling its own expression as well as other
IE genes that are critical to maintaining
latency. MicroRNA (miRNA)-mediated
silencing has garnered considerable
attention as a potential mechanism for
this regulation during latency (Cullen,
2011). Consistent with this hypothesis,
members of both the Herpesviridae andPolyomaviridae families encode autore-
gulatory miRNAs that control expression
of their lytic genes. For example, the LAT
locus of HSV-1 encodes several miRNAs
(Umbach et al., 2008; Jurak et al., 2011),
which have been linked to downregula-
tion of the IE genes ICP0 and ICP34.5
(Umbach et al., 2008). Thus, it is firmly
established that diverse viruses can use
miRNAs to regulate the expression of
their own genes—a potential factor in
both establishing and maintaining latent
infections.
miRNA regulation is prevalent in multi-
cellular eukaryotes and, directly or indi-
rectly, likely regulates all cellular path-
ways. miRNAs are central components
of the RNA-induced silencing complex
(RISC), targeting it to messenger RNAs
(mRNAs) via base pairing. Numerous
miRNAs have cell-type-specific expres-
sion, making them attractive candidates
as host factors involved in circumstan-
tial regulation of lytic gene expression.
Indeed, there are examples of host
miRNAs affecting the cell-type-specific
gene expression of diverse viruses (Gu-
nasekharan and Laimins, 2013; Tro-
baugh et al., 2014; Jopling et al., 2005).
Despite what is known, many questions
remain regarding the extent to which
host miRNAs are coopted ore 15, April 9, 2014 ª2014 Elsevier Inc. 395
